New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia.
Cristina Alonso-VegaJulio A UrbinaSergi SanzMaría-Jesús PinazoJimy José PintoVirginia R GonzalezGimena RojasLourdes OrtizWilson GarciaDaniel LozanoDolors SoyRosa A MaldonadoRana NagarkattiAlain DebrabantAlejandro SchijmanM Carmen ThomasManuel Carlos LópezKatja MichaelIsabela RibeiroJoaquim GasconFaustino TorricoIgor Correia de AlmeidaPublished in: BMJ open (2021)
NCT03981523.